Skip to content

Clinical trials

Hyperkalemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hyperkalemia Country / region: United States Clear all

50 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20082
20091
20111
20121
20132
20144
20153
20161
20176
20184
20193
20203
20219
20223
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Terminated12
Recruiting4
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
ZS Pharma, Inc.8
Relypsa, Inc.5
Vifor Pharma, Inc.3
Ardelyx2
US Department of Veterans Affairs2
AccurKardia, Inc.1
Baylor Research Institute1
Brigham and Women's Hospital1
Comprehensive Research Associates1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hyperkalemia50
Renal Insufficiency, Chronic17
Heart Failure6
Hypertension3
Kidney Failure, Chronic3
Acidosis2
Albuminuria2
Atrial Fibrillation2
Diabetes Mellitus, Type 22
Emergencies2

Trials

Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.